ProtokolPROTOKOL
Medication

Ozempic (Semaglutide pen)

Half-life

~7 days

What is Ozempic (Semaglutide pen)?

Weekly GLP-1 receptor agonist for glycemic control and weight reduction.

How Ozempic (Semaglutide pen) works

GLP-1 receptor agonism increases glucose-dependent insulin secretion, reduces glucagon, and slows gastric emptying/appetite.

Ozempic (Semaglutide pen) half-life

~7 days

Ozempic (Semaglutide pen) side effects

  • Nausea/vomiting
  • Constipation
  • Gallbladder/pancreatitis warnings

Track Ozempic (Semaglutide pen) in Protokol.

Log doses, model half-lives, check interactions, and line it all up against your bloodwork. Free on iPhone and Android.

Download on the App StoreGet it on Google Play

For research and educational purposes only. This page is not medical advice and is not a recommendation to use any compound. Many compounds listed are not approved for human use, and some are prescription-only or controlled in your jurisdiction. Dosing figures are reference or observational reports. Talk to a qualified healthcare provider before starting, stopping, or changing anything. Protokol is for tracking purposes only.